Methods of treating erythropoietin-resistance

Details Methods of treating erythropoietin-resistance Methods of treating erythropoietin-resistance

A - Human Necessities

61

K

A61K 31/4412 (2006.01) A61K 31/00 (2006.01) A61K 31/198 (2006.01) A61K 31/4196 (2006.01) A61K 31/426 (2006.01) A61K 31/45 (2006.01) A61P 7/06 (2006.01) A61P 39/04 (2006.01)

Patent

CA 2587558

A human having an erythropoietin resistant condition is treated by the administration of an iron chelator. The human can have end-stage renal disease, chronic renal disease, cancer or anemia. Administration of the iron chelator can essentially halt or diminish an erythropoietin resistant condition in a human.

L~invention concerne le traitement d~un état de résistance à l~érythropoïétine chez un être humain par administration d~un chélateur du fer. L~être humain peut présenter une insuffisance rénale terminale, une insuffisance rénale chronique, un cancer ou une anémie. L~administration du chélateur du fer peut essentiellement bloquer ou diminuer l~état de résistance à l~érythropoïétine chez un être humain.

Affiliated with

Also associated with

Rating

Methods of treating erythropoietin-resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating erythropoietin-resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating erythropoietin-resistance will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1943673